NeuroSense Presents PrimeC Study Data at NEALS Annual Meeting
NeuroSense Therapeutics presented PrimeC study data at the NEALS annual meeting.
Related stories
Mondelez Q3 profit exceeds expectations as cost pressures ease
Reuters reports Mondelez International’s third-quarter profit exceeded expectations as cost pressures eased.
M impact | EQUITY | Oct 29, 2026, 09:21 PM UTC
Erie Indemnity Q3 Profit Falls to $181.989 Million
Erie Indemnity reported third-quarter profit of $181.989 million, or $3.48 per share, compared with $182.853 million, or $3.50 per share, a year earlier. Revenue rose, but the repo
M impact | EQUITY | Oct 29, 2026, 09:21 PM UTC
Southern Missouri Bancorp CFO Chkautovich to Resign November 7
CFO Stefan Chkautovich will resign effective November 7 to pursue another professional opportunity. The filing names Funke as principal financial officer.
M impact | EQUITY | Oct 29, 2026, 09:19 PM UTC
Coinbase Q3 transaction revenue is $590 million
M impact | EQUITY | Oct 29, 2026, 09:19 PM UTC
JioBlackRock Broking Appoints Nikhil Dhoka CEO
Nikhil Dhoka, a former Kotak Neo executive, has taken charge as CEO of JioBlackRock Broking, the brokerage arm of the Jio Financial Services–BlackRock joint venture.
M impact | EQUITY | Oct 29, 2026, 09:19 PM UTC
Donaldson Signs Note Purchase Agreement for Up to $1.5 Billion
Donaldson signed a note purchase agreement with institutional investors for up to $1.5 billion.
M impact | EQUITY | Oct 29, 2026, 09:18 PM UTC